Deutsche Bank’s Verrica Pharmaceuticals VRCA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-59
| Closed | -$260 | – | 3715 |
|
2025
Q1 | $260 | Hold |
59
| – | – | ﹤0.01% | 3527 |
|
2024
Q4 | $414 | Hold |
59
| – | – | ﹤0.01% | 3514 |
|
2024
Q3 | $857 | Sell |
59
-18,143
| -100% | -$264K | ﹤0.01% | 3506 |
|
2024
Q2 | $1.33M | Sell |
18,202
-155
| -0.8% | -$11.3K | ﹤0.01% | 1828 |
|
2024
Q1 | $1.09M | Buy |
18,357
+9,802
| +115% | +$580K | ﹤0.01% | 1951 |
|
2023
Q4 | $626K | Buy |
8,555
+8,544
| +77,673% | +$625K | ﹤0.01% | 2227 |
|
2023
Q3 | $443 | Buy |
+11
| New | +$443 | ﹤0.01% | 3605 |
|
2022
Q2 | – | Sell |
-732
| Closed | -$60K | – | 4145 |
|
2022
Q1 | $60K | Sell |
732
-84
| -10% | -$6.89K | ﹤0.01% | 3706 |
|
2021
Q4 | $75K | Buy |
816
+42
| +5% | +$3.86K | ﹤0.01% | 3736 |
|
2021
Q3 | $97K | Sell |
774
-32
| -4% | -$4.01K | ﹤0.01% | 3844 |
|
2021
Q2 | $91K | Sell |
806
-25
| -3% | -$2.82K | ﹤0.01% | 4074 |
|
2021
Q1 | $126K | Sell |
831
-75
| -8% | -$11.4K | ﹤0.01% | 3804 |
|
2020
Q4 | $104K | Buy |
906
+251
| +38% | +$28.8K | ﹤0.01% | 3752 |
|
2020
Q3 | $51K | Buy |
655
+61
| +10% | +$4.75K | ﹤0.01% | 3822 |
|
2020
Q2 | $65K | Buy |
594
+175
| +42% | +$19.2K | ﹤0.01% | 3623 |
|
2020
Q1 | $46K | Sell |
419
-26
| -6% | -$2.85K | ﹤0.01% | 3510 |
|
2019
Q4 | $69K | Buy |
445
+89
| +25% | +$13.8K | ﹤0.01% | 3689 |
|
2019
Q3 | $51K | Sell |
356
-634
| -64% | -$90.8K | ﹤0.01% | 3810 |
|
2019
Q2 | $114K | Sell |
990
-356
| -26% | -$41K | ﹤0.01% | 4020 |
|
2019
Q1 | $144K | Buy |
1,346
+588
| +78% | +$62.9K | ﹤0.01% | 4054 |
|
2018
Q4 | $61K | Sell |
758
-560
| -42% | -$45.1K | ﹤0.01% | 4195 |
|
2018
Q3 | $214K | Buy |
+1,318
| New | +$214K | ﹤0.01% | 4106 |
|